• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies.使用光学技术评估宫颈发育异常时诊断和筛查人群的流行病学差异。
Gend Med. 2012 Feb;9(1 Suppl):S36-47. doi: 10.1016/j.genm.2011.10.006.
2
Human papillomavirus infection and its association with cervical dysplasia in Ecuadorian women attending a private cancer screening clinic.厄瓜多尔妇女在私立癌症筛查诊所就诊时的人乳头瘤病毒感染及其与宫颈发育不良的关系。
Braz J Med Biol Res. 2009 Jul;42(7):629-36. doi: 10.1590/s0100-879x2009000700007.
3
Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa.在南非约翰内斯堡,人类免疫缺陷病毒感染女性中,人乳头瘤病毒种类多样且感染率高,伴有显著较高的宫颈发育异常率。
Acta Cytol. 2009 Jan-Feb;53(1):10-7. doi: 10.1159/000325079.
4
[Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].[CINtec p16INK4a免疫细胞化学检测在筛查宫颈前病变中的可靠性]
Vojnosanit Pregl. 2008 Mar;65(3):211-9. doi: 10.2298/vsp0803211j.
5
Prevalence of genital human papillomavirus among Lebanese women.黎巴嫩女性生殖道人乳头瘤病毒的流行情况。
Eur J Gynaecol Oncol. 2002;23(5):429-32.
6
Human papilloma virus infection and cervical dysplasia.人乳头瘤病毒感染与宫颈发育异常。
Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):853-7.
7
Pap test results among low-income youth: prevalence of dysplasia and practice implications.低收入青年的巴氏试验结果:发育异常的患病率及实际意义。
J Obstet Gynecol Neonatal Nurs. 2002 May-Jun;31(3):294-304. doi: 10.1111/j.1552-6909.2002.tb00051.x.
8
[Detection and genotyping of high-risk human papillomavirus in cervical specimens].宫颈标本中高危型人乳头瘤病毒的检测与基因分型
Enferm Infecc Microbiol Clin. 2007 May;25(5):311-6. doi: 10.1157/13102266.
9
Spectrum of genital human papillomavirus infection in a female adolescent population.女性青少年人群中生殖器人乳头瘤病毒感染的谱系
Sex Transm Dis. 1995 Jul-Aug;22(4):236-43. doi: 10.1097/00007435-199507000-00007.
10
High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program.法国女性医院队列中,超出年龄上限筛查项目范围的宫颈涂片异常患病率较高。
Prev Med. 2015 Dec;81:157-62. doi: 10.1016/j.ypmed.2015.08.018. Epub 2015 Sep 5.

引用本文的文献

1
Polymorphisms in the Nonhomologous End-joining DNA Repair Pathway are Associated with HPV Integration in Cervical Dysplasia.非同源末端连接 DNA 修复途径中的多态性与宫颈发育不良中的 HPV 整合有关。
Cancer Prev Res (Phila). 2023 Aug 1;16(8):461-469. doi: 10.1158/1940-6207.CAPR-23-0051.
2
Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.种族/民族差异 HPV16/18 基因型和整合状态在有细胞学异常史的女性中。
Gynecol Oncol. 2018 Feb;148(2):357-362. doi: 10.1016/j.ygyno.2017.12.014. Epub 2017 Dec 21.
3
Association of traffic-related hazardous air pollutants and cervical dysplasia in an urban multiethnic population: a cross-sectional study.城市多民族人群中交通相关有害空气污染物与宫颈发育异常的关联:一项横断面研究。
Environ Health. 2014 Jun 13;13(1):52. doi: 10.1186/1476-069X-13-52.
4
Sociodemographic factors associated with pap test adherence and cervical dysplasia in surgically sterilized women.与接受绝育手术女性的巴氏试验依从性和宫颈发育异常相关的社会人口学因素。
J Reprod Infertil. 2014 Apr;15(2):94-104.
5
Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy.光学光谱法检测宫颈上皮内瘤变的准确性:一种作为阴道镜检查辅助手段的设备检测。
Int J Cancer. 2011 Mar 1;128(5):1151-68. doi: 10.1002/ijc.25667. Epub 2010 Nov 9.

本文引用的文献

1
A follow-up study of atypical squamous cells in gynecologic cytology using conventional papanicolaou smears and liquid-based preparations: the impact of the Bethesda System 2001.
Am J Clin Pathol. 2007 Apr;127(4):548-55. doi: 10.1309/21U34K8YW053F21E.
2
Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues.用于衡量12位病理学家对1790份宫颈活检标本的评分者间和评分者内一致性的kappa统计量:定性组织病理学分析及方法学问题
Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S38-52. doi: 10.1016/j.ygyno.2005.07.040. Epub 2005 Sep 23.
3
Global cancer statistics, 2002.2002年全球癌症统计数据。
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
4
The health care costs of cervical human papillomavirus--related disease.宫颈人乳头瘤病毒相关疾病的医疗费用
Am J Obstet Gynecol. 2004 Jul;191(1):114-20. doi: 10.1016/j.ajog.2004.01.042.
5
Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients--assessing their roles as human papillomavirus cofactors.
J Natl Cancer Inst Monogr. 2003(31):29-34. doi: 10.1093/oxfordjournals.jncimonographs.a003478.
6
Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.第3章:人乳头瘤病毒致癌作用中的辅助因素——生育次数、口服避孕药及吸烟的作用
J Natl Cancer Inst Monogr. 2003(31):20-8.
7
American Cancer Society guideline for the early detection of cervical neoplasia and cancer.美国癌症协会子宫颈瘤变和癌症早期检测指南。
CA Cancer J Clin. 2002 Nov-Dec;52(6):342-62. doi: 10.3322/canjclin.52.6.342.
8
Reflectance spectroscopy for in vivo detection of cervical precancer.用于宫颈癌前病变体内检测的反射光谱学。
J Biomed Opt. 2002 Oct;7(4):587-94. doi: 10.1117/1.1502675.
9
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.产次与人乳头瘤病毒在宫颈癌中的作用:国际癌症研究机构多中心病例对照研究
Lancet. 2002 Mar 30;359(9312):1093-101. doi: 10.1016/S0140-6736(02)08151-5.
10
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.口服避孕药对人乳头瘤病毒感染女性患宫颈癌风险的影响:国际癌症研究机构多中心病例对照研究
Lancet. 2002 Mar 30;359(9312):1085-92. doi: 10.1016/S0140-6736(02)08150-3.

使用光学技术评估宫颈发育异常时诊断和筛查人群的流行病学差异。

Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies.

作者信息

Pham Bryan, Rhodes Helen, Milbourne Andrea, Adler-Storthz Karen, Follen Michele, Scheurer Michael E

机构信息

Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

Gend Med. 2012 Feb;9(1 Suppl):S36-47. doi: 10.1016/j.genm.2011.10.006.

DOI:10.1016/j.genm.2011.10.006
PMID:22340639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3874883/
Abstract

BACKGROUND

We report here the logistic modeling of the epidemiologic differences between a diagnostic population and a screening population recruited for the study of optical technologies for cervical cancer detection.

OBJECTIVES

The goal of this analysis was to determine if there were differences in the sociodemographic or clinical factors between subjects recruited to our diagnostic and screening trials.

METHODS

Epidemiologic data were obtained from a risk factor interview as a component of a multicenter Phase II clinical trial that used fluorescence and reflectance point spectroscopy to diagnose cervical disease. Participants with recent or past abnormal findings on a Papanicolaou smear were grouped into the diagnostic (high-risk) population, whereas those with a history of normal findings on Papanicolaou smears and no cervical treatments were grouped into the screening (low-risk) population.

RESULTS

Our model revealed that nonwhite race, higher than a high school education, and peri- and postmenopausal status were associated with the screening population. A history of genital infections, current oral contraceptive use, human papillomavirus positivity (by Hybrid Capture II and consensus polymerase chain reaction), and worst histological diagnosis at clinic visit were important predictors of being in the diagnostic group.

CONCLUSIONS

We were successful in recruiting 2 distinctive populations and anticipate being able to use these results to more correctly classify women at higher risk for cervical lesions in our future studies of optical spectroscopy.

摘要

背景

我们在此报告为研究用于宫颈癌检测的光学技术而招募的诊断人群和筛查人群之间流行病学差异的逻辑模型。

目的

本分析的目的是确定参与我们诊断性试验和筛查性试验的受试者在社会人口统计学或临床因素方面是否存在差异。

方法

流行病学数据来自危险因素访谈,该访谈是一项多中心II期临床试验的一部分,该试验使用荧光和反射点光谱法诊断宫颈疾病。巴氏涂片检查近期或过去有异常结果的参与者被归入诊断(高风险)人群,而巴氏涂片检查结果正常且未接受宫颈治疗的参与者被归入筛查(低风险)人群。

结果

我们的模型显示,非白人种族、高中以上学历以及围绝经期和绝经后状态与筛查人群相关。生殖器感染史、当前口服避孕药的使用、人乳头瘤病毒阳性(通过杂交捕获II和一致性聚合酶链反应)以及就诊时最严重的组织学诊断是诊断组的重要预测因素。

结论

我们成功招募了两个不同的人群,并预计能够利用这些结果在未来的光谱学研究中更准确地对宫颈癌病变高危女性进行分类。